TECX Tectonic Therapeutic Inc.
Price (delayed)
$18.36
Market cap
$270.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$14.3
Enterprise value
$88.26M
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
Highlights
Tectonic Therapeutic's equity has soared by 87% from the previous quarter and by 36% YoY
The EPS has grown by 50% year-on-year and by 23% since the previous quarter
TECX's net income is up by 40% year-on-year but it is down by 4.7% since the previous quarter
Tectonic Therapeutic's quick ratio has plunged by 72% from the previous quarter and by 33% YoY
TECX's debt is up by 44% year-on-year
Key stats
What are the main financial stats of TECX
Market
Valuations
Earnings
Shares outstanding
14.73M
Market cap
$270.53M
Enterprise value
$88.26M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.41
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$52.1M
EBITDA
-$50.07M
Free cash flow
-$49.56M
Per share
Balance sheet
Liquidity
EPS
-$14.3
Free cash flow per share
-$16.97
Book value per share
$44.47
Revenue per share
$0
TBVPS
$66.41
Total assets
$193.91M
Total liabilities
$27.54M
Debt
$3.44M
Equity
$166.37M
Working capital
$161.39M
Debt to equity
0.02
Current ratio
7.21
Quick ratio
7.14
Net debt/EBITDA
3.64
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.7%
Return on equity
-72.9%
Return on invested capital
N/A
Return on capital employed
-31%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TECX stock price
How has the Tectonic Therapeutic stock price performed over time
Intraday
0.49%
1 week
-4.38%
1 month
8.57%
1 year
-5.56%
YTD
12.5%
QTD
11.48%
Financial performance
How have Tectonic Therapeutic's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$51.96M
Net income
-$49.84M
Gross margin
N/A
Net margin
N/A
TECX's net income is up by 40% year-on-year but it is down by 4.7% since the previous quarter
TECX's operating income is up by 38% year-on-year
Growth
What is Tectonic Therapeutic's growth rate over time
Valuation
What is Tectonic Therapeutic stock price valuation
P/E
N/A
P/B
0.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 50% year-on-year and by 23% since the previous quarter
Tectonic Therapeutic's equity has soared by 87% from the previous quarter and by 36% YoY
TECX's price to book (P/B) is 68% less than its 5-year quarterly average of 1.3
Efficiency
How efficient is Tectonic Therapeutic business performance
The return on assets has increased by 38% year-on-year and by 10% since the previous quarter
Tectonic Therapeutic's ROE has increased by 24% YoY and by 12% from the previous quarter
Dividends
What is TECX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TECX.
Financial health
How did Tectonic Therapeutic financials performed over time
The total liabilities has soared by 133% YoY
The total assets has surged by 110% since the previous quarter and by 45% year-on-year
TECX's debt is 98% smaller than its equity
Tectonic Therapeutic's equity has soared by 87% from the previous quarter and by 36% YoY
TECX's debt is up by 44% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.